Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Alimera Sciences, Inc. (ALIM) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Alimera Sciences, Inc. (ALIM) - free report >>
Image: Bigstock
New Strong Sell Stocks for March 1st
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Agios Pharmaceuticals (AGIO - Free Report) : is a biopharmaceutical company focused on development of treatments for rare genetic metabolic disorders, a subset of orphan genetic metabolic diseases. The Zacks Consensus Estimate for its current year earnings has been revised 26.6% downward over the last 60 days.
Alimera Sciences (ALIM - Free Report) : is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Zacks Consensus Estimate for its current year earnings has been revised 302.1% downward over the last 60 days.
BrightView (BV - Free Report) ): is a provider of commercial landscaping services primarily in the United States. The Zacks Consensus Estimate for its current year earnings has been revised almost 7.4% downward over the last 60 days.
View the entire Zacks Rank #5 List.